{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T09:35:40Z","timestamp":1758274540281},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1038\/s41443-018-0102-y","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T16:09:18Z","timestamp":1551802158000},"page":"61-64","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Sildenafil in postprostatectomy erectile dysfunction (perspective)"],"prefix":"10.1038","volume":"31","author":[{"given":"Mikkel","family":"Fode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian Fuglesang S.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Busch","family":"\u00d8stergren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,5]]},"reference":[{"key":"102_CR1","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1056\/NEJMoa1606220","volume":"375","author":"FC Hamdy","year":"2016","unstructured":"Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P, et al. 10-Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med. 2016;375:1415.","journal-title":"N Engl J Med"},{"key":"102_CR2","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.eururo.2009.11.009","volume":"57","author":"J Walz","year":"2010","unstructured":"Walz J, Burnett AL, Costello AJ, Eastham JA, Graefen M, Guillonneau B, et al. A critical analysis of the current knowledge of surgical anatomy related to optimization of cancer control and preservation of continence and erection in candidates for radical prostatectomy. Eur Urol. 2010;57:179.","journal-title":"Eur Urol"},{"key":"102_CR3","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0022-5347(17)53012-8","volume":"128","author":"PC Walsh","year":"1982","unstructured":"Walsh PC, Donker PJ. Impotence following radical prostatectomy: insight into etiology and prevention. J Urol. 1982;128:492.","journal-title":"J Urol"},{"key":"102_CR4","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3109\/21681805.2015.1102964","volume":"50","author":"M Fode","year":"2016","unstructured":"Fode M, Frey A, Jakobsen H, Sonksen J. Erectile function after radical prostatectomy: do patients return to baseline? Scand J Urol. 2016;50:160.","journal-title":"Scand J Urol"},{"key":"102_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0090-4295(02)02271-9","volume":"61","author":"AL Burnett","year":"2003","unstructured":"Burnett AL. Rationale for cavernous nerve restorative therapy to preserve erectile function after radical prostatectomy. Urology. 2003;61:491.","journal-title":"Urology"},{"key":"102_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1172\/JCI116220","volume":"91","author":"N Kim","year":"1993","unstructured":"Kim N, Vardi Y, Padma-Nathan H, Daley J, Goldstein I, Saenz DT,I. Oxygen tension regulates the nitric oxide pathway. Physiological role in penile erection. J Clin Invest. 1993;91:437.","journal-title":"J Clin Invest"},{"key":"102_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.eururo.2008.10.028","volume":"55","author":"K Hatzimouratidis","year":"2009","unstructured":"Hatzimouratidis K, Burnett AL, Hatzichristou D, McCullough AR, Montorsi F, Mulhall JP. Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application. Eur Urol. 2009;55:334.","journal-title":"Eur Urol"},{"key":"102_CR8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1097\/01.ju.0000154356.76027.4f","volume":"173","author":"F Iacono","year":"2005","unstructured":"Iacono F, Giannella R, Somma P, Manno G, Fusco F, Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol. 2005;173:1673.","journal-title":"J Urol"},{"key":"102_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/sj.ijir.3901596","volume":"20","author":"L Vignozzi","year":"2008","unstructured":"Vignozzi L, Morelli A, Filippi S, Vannelli GB, Mungai S, Marini M, et al. Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. Int J Impot Res. 2008;20:60.","journal-title":"Int J Impot Res"},{"key":"102_CR10","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1111\/j.1743-6109.2008.00794.x","volume":"5","author":"JP Mulhall","year":"2008","unstructured":"Mulhall JP, Muller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, et al. The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate. J Sex Med. 2008;5:1126.","journal-title":"J Sex Med"},{"key":"102_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/sj.ijir.3901612","volume":"20","author":"I Kovanecz","year":"2008","unstructured":"Kovanecz I, Rambhatla A, Ferrini M, Vernet D, Sanchez S, Rajfer J, et al. Long-term continuous sildenafil treatment ameliorates corporal veno-occlusive dysfunction (CVOD) induced by cavernosal nerve resection in rats. Int J Impot Res. 2008;20:202.","journal-title":"Int J Impot Res"},{"key":"102_CR12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.urology.2010.10.009","volume":"77","author":"E Ozden","year":"2011","unstructured":"Ozden E, Ozturk B, Kosan M, Tezel GG, Aki FT, Gur S, et al. Effect of sildenafil citrate on penile weight and physiology of cavernous smooth muscle in a post-radical prostatectomy model of erectile dysfunction in rats. Urology. 2011;77:761.","journal-title":"Urology"},{"key":"102_CR13","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/j.1743-6109.2010.02195.x","volume":"8","author":"F Sirad","year":"2011","unstructured":"Sirad F, Hlaing S, Kovanecz I, Artaza JN, Garcia LA, Rajfer J, et al. Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat. J Sex Med. 2011;8:1048.","journal-title":"J Sex Med"},{"key":"102_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1097\/01.ju.0000106970.97082.61","volume":"171","author":"EJ Schwartz","year":"2004","unstructured":"Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004;171:771.","journal-title":"J Urol"},{"key":"102_CR15","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1159\/000127335","volume":"80","author":"F Iacono","year":"2008","unstructured":"Iacono F, Prezioso D, Somma P, Chierchia S, Galasso R, Micheli P. Histopathologically proven prevention of post-prostatectomy cavernosal fibrosis with sildenafil. Urol Int. 2008;80:249.","journal-title":"Urol Int"},{"key":"102_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/ijir.2008.33","volume":"20","author":"H Padma-Nathan","year":"2008","unstructured":"Padma-Nathan H, McCullough AR, Levine LA, Lipshultz LI, Siegel R, Montorsi F, et al. Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res. 2008;20:479.","journal-title":"Int J Impot Res"},{"key":"102_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1743-6109.2007.00700.x","volume":"5","author":"AR McCullough","year":"2008","unstructured":"McCullough AR, Levine LA, Padma-Nathan H. Return of nocturnal erections and erectile function after bilateral nerve-sparing radical prostatectomy in men treated nightly with sildenafil citrate: subanalysis of a longitudinal randomized double-blind placebo-controlled trial. J Sex Med. 2008;5:476.","journal-title":"J Sex Med"},{"key":"102_CR18","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.eururo.2008.06.083","volume":"54","author":"F Montorsi","year":"2008","unstructured":"Montorsi F, Brock G, Lee J, Shapiro J, Van PH, Graefen M, et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol. 2008;54:924.","journal-title":"Eur Urol"},{"key":"102_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.eururo.2013.09.051","volume":"65","author":"F Montorsi","year":"2014","unstructured":"Montorsi F, Brock G, Stolzenburg JU, Mulhall J, Moncada I, Patel HR, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2014;65:587.","journal-title":"Eur Urol"},{"key":"102_CR20","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/bju.12253","volume":"112","author":"CP Pavlovich","year":"2013","unstructured":"Pavlovich CP, Levinson AW, Su LM, Mettee LZ, Feng Z, Bivalacqua TJ, et al. Nightly vs on-demand sildenafil for penile rehabilitation after minimally invasive nerve-sparing radical prostatectomy: results of a randomized double-blind trial with placebo. BJU Int. 2013;112:844.","journal-title":"BJU Int"},{"key":"102_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/andr.12118","volume":"4","author":"DJ Kim","year":"2016","unstructured":"Kim DJ, Hawksworth DJ, Hurwitz LM, Cullen J, Rosner IL, Lue TF, et al. A prospective, randomized, placebo-controlled trial of on-demand vs. nightly sildenafil citrate as assessed by Rigiscan and the international index of erectile function. Andrology. 2016;4:27.","journal-title":"Andrology"},{"key":"102_CR22","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1016\/j.juro.2017.12.060","volume":"199","author":"JK Jo","year":"2018","unstructured":"Jo JK, Jeong SJ, Oh JJ, Lee SW, Lee S, Hong SK, et al. Effect of starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy on erectile function recovery: a prospective randomized trial. J Urol. 2018;199:1600.","journal-title":"J Urol"},{"key":"102_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1517\/17425255.1.2.283","volume":"1","author":"SH Francis","year":"2005","unstructured":"Francis SH, Corbin JD. Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction. Expert Opin Drug Metab Toxicol. 2005;1:283.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"102_CR24","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1073\/pnas.052712499","volume":"99","author":"KJ Hurt","year":"2002","unstructured":"Hurt KJ, Musicki B, Palese MA, Crone JK, Becker RE, Moriarity JL, et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc Natl Acad Sci USA. 2002;99:4061.","journal-title":"Proc Natl Acad Sci USA"},{"key":"102_CR25","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1111\/j.1743-6109.2011.02355.x","volume":"8","author":"R Tal","year":"2011","unstructured":"Tal R, Teloken P, Mulhall JP. Erectile function rehabilitation after radical prostatectomy: practice patterns among AUA members. J Sex Med. 2011;8:2370.","journal-title":"J Sex Med"}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0102-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41443-018-0102-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:44Z","timestamp":1684618124000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-018-0102-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["102"],"URL":"https:\/\/doi.org\/10.1038\/s41443-018-0102-y","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"13 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MF is a speaker for Astellas Pharma and Ferring Pharmaceuticals and an advisory board member for Astellas Pharma. PB\u00d8 is a speaker for Astellas Pharma, Ferring Pharmaceuticals, and Ipsen, and an advisory board member for Astellas Pharma and Ipsen. CFSJ declare that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}